Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry Lebret

Showing results (111-120 of 147) with videos related to

Pageof 15
Sort By:
International Journal of Cancer|October 15, 2013
PI3K/AKT pathway activation in bladder carcinogenesisJulien Calderaro, Sandra Rebouissou, Leanne de Koning, et al.
Cancers|September 9, 2023
A Case-Only Genome-Wide Interaction Study of Smoking and Bladder Cancer Risk: Results from the COBLAnCE CohortMaryam Karimi, Sebastian Mendez-Pineda, Hélène Blanché, et al.
World Journal of Urology|April 13, 2024
Is "Kidney Stone Calculator" efficient in predicting ureteroscopic lithotripsy duration? A holmium:YAG and thulium fiber lasers comparative analysisMarie Chicaud, Stessy Kutchukian, Steeve Doizi, et al.
World Journal of Urology|June 26, 2025
From laser-on time to lithotripsy duration: improving the prediction of lithotripsy duration with 'Kidney Stone Calculator' using artificial intelligenceFrédéric Panthier, Laurent Berthe, Chady Ghnatios, et al.
The French Journal of Urology|June 26, 2026
Shifting Risk Profile in Radical Prostatectomy Over 18 Years: A Bicentric French Study of 8,358 PatientsYann Neuzillet, Joao Paulo Barbosa De Oliveira, François Rozet, et al.
EMBO Molecular Medicine|October 22, 2013
An essential role for decorin in bladder cancer invasivenessMohamed El Behi, Sophie Krumeich, Catalina Lodillinsky, et al.
The Journal of Pathology|October 6, 2021
Multilayer spectrum of intratumoral heterogeneity in basal bladder cancerNanor Sirab, Damien Drubay, Pascale Maillé, et al.
European Urology Oncology|August 29, 2024
Final Results of the ANDROCAN Study: Histopathological Characteristics and Biochemical Recurrence at 5 Years of Localized Prostate Cancer According to Preoperative Gonadal StatusYann Neuzillet, Jean-Pierre Raynaud, Jean-François Dreyfus, et al.
Hormones & Cancer|October 8, 2018
Aggressiveness of Localized Prostate Cancer: the Key Value of Testosterone Deficiency Evaluated by Both Total and Bioavailable Testosterone: AndroCan Study ResultsYann Neuzillet, Jean-Pierre Raynaud, Jean-François Dreyfus, et al.
The Journal of Pathology|March 17, 2012
CDKN2A homozygous deletion is associated with muscle invasion in FGFR3-mutated urothelial bladder carcinomaSandra Rebouissou, Aurélie Hérault, Eric Letouzé, et al.
Pageof 15

Showing results (111-120 of 147) with videos related to

Sort By:
Pageof 15
International Journal of Cancer|October 15, 2013
PI3K/AKT pathway activation in bladder carcinogenesisJulien Calderaro, Sandra Rebouissou, Leanne de Koning, et al.
Cancers|September 9, 2023
A Case-Only Genome-Wide Interaction Study of Smoking and Bladder Cancer Risk: Results from the COBLAnCE CohortMaryam Karimi, Sebastian Mendez-Pineda, Hélène Blanché, et al.
World Journal of Urology|April 13, 2024
Is "Kidney Stone Calculator" efficient in predicting ureteroscopic lithotripsy duration? A holmium:YAG and thulium fiber lasers comparative analysisMarie Chicaud, Stessy Kutchukian, Steeve Doizi, et al.
World Journal of Urology|June 26, 2025
From laser-on time to lithotripsy duration: improving the prediction of lithotripsy duration with 'Kidney Stone Calculator' using artificial intelligenceFrédéric Panthier, Laurent Berthe, Chady Ghnatios, et al.
The French Journal of Urology|June 26, 2026
Shifting Risk Profile in Radical Prostatectomy Over 18 Years: A Bicentric French Study of 8,358 PatientsYann Neuzillet, Joao Paulo Barbosa De Oliveira, François Rozet, et al.
EMBO Molecular Medicine|October 22, 2013
An essential role for decorin in bladder cancer invasivenessMohamed El Behi, Sophie Krumeich, Catalina Lodillinsky, et al.
The Journal of Pathology|October 6, 2021
Multilayer spectrum of intratumoral heterogeneity in basal bladder cancerNanor Sirab, Damien Drubay, Pascale Maillé, et al.
European Urology Oncology|August 29, 2024
Final Results of the ANDROCAN Study: Histopathological Characteristics and Biochemical Recurrence at 5 Years of Localized Prostate Cancer According to Preoperative Gonadal StatusYann Neuzillet, Jean-Pierre Raynaud, Jean-François Dreyfus, et al.
Hormones & Cancer|October 8, 2018
Aggressiveness of Localized Prostate Cancer: the Key Value of Testosterone Deficiency Evaluated by Both Total and Bioavailable Testosterone: AndroCan Study ResultsYann Neuzillet, Jean-Pierre Raynaud, Jean-François Dreyfus, et al.
The Journal of Pathology|March 17, 2012
CDKN2A homozygous deletion is associated with muscle invasion in FGFR3-mutated urothelial bladder carcinomaSandra Rebouissou, Aurélie Hérault, Eric Letouzé, et al.
Pageof 15